Skip to content
healthcare.dev

Fyremadel

NDC 55566-1010, ganirelix acetate, injection, solution, from Ferring Pharmaceuticals Inc..

Product NDC
55566-1010
Status
Listed
Labeler
Ferring Pharmaceuticals Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204246
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55566-1010 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GANIRELIX ACETATE250 ug/.5mL

Pharmacologic classes

Decreased GnRH Secretion [PE]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]; Gonadotropin Releasing Hormone Receptor Antagonists [MoA]

Package NDCNDC-11Package
55566-1010-1555661010011 BLISTER PACK in 1 CARTON (55566-1010-1) / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5f0908b5-3551-47fd-95f7-3669b0dff7f1
  • NADAC price for package 55566101001

    GET /v1/drugs/nadac/55566101001

Use it

Look up 55566-1010 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55566-1010 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55566-1010. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.